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Abstract
Background: Hyaluronic acid (HA) dermal biphasic fillers are synthesized for their efficacy in correcting aesthetic
defects such as wrinkles, scars and facial contouring defects. The fillers consist of crosslinked HA microspheres
suspended in a noncrosslinked HA. To extend the duration of HAs within the dermis and obtain the particle
texturing feel, HAs are crosslinked to obtain the suitable mechanical properties.
Results: Hyaluronic acid (HA) dermal biphasic fillers are prepared by mixing the crosslinked HA microspheres and
the noncrosslinked HAs. The elastic modulus of the fillers increased with raising the volume fraction of the microspheres.
The mechanical properties and the particle texturing feel of the fillers made from crosslinked HA (1058 kDa) microspheres
suspended in noncrosslinked HA (1368 kDa) are successfully achieved, which are adequate for the fillers.
Conclusions: Dermal biphasic HA fillers made from 1058 kDa exhibit suitable elastic moduli (211 to 420 Pa) and particle
texturing feel (scale 7 ~ 9).
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Background
In its natural state, hyaluronic acid (HA) exhibits poor
biomechanical properties as a dermal fillers due to the
poor viscoelasticity and the short half-life of HA when
injected into normal skin [1–11]. To provide the ability
to lift and fill wrinkles in the skin, chemical modification
is required to improve its mechanical properties. Cross-
linking is attempted to improve biomechanical properties
while maintaining biocompatibility and biological activity
[1–11]. HA dermal fillers are classified into two types,
monophasic and biphasic [3–8]. Monophasic HA fillers
(Surgiderm 24XP, England, Juvederm Ultra™, USA) are
known as solely crosslinked and non-particulate HA gels
[3, 4]. The monophasic fillers are prepared by mixing the
high-molecular-weight HA and the low-molecular-weight
HA. They have weak strength of gel and can easily trans-
form by external force. No appreciable particle texturing
can be felt when touching gels with hands. In contrast,
biphasic fillers (Restylane®, Q-Med, Sweden) consist of gel
particles of stabilized HA suspended in a noncrosslinked
HA (NHA) [3, 4]. The crosslinked HA (CHA) gel particles
are suspended in NHA, which acts as a lubricant, allowing
the suspension to be pushed through a fine needle [4].
They are reported to have a rapid initial degradation of
NHA and a slower degradation of the crosslinked gel
particles, whereas monophasic gels are degraded more
uniformly [3–5]. Restylane® is a FDA-approved dermal
filler made of a biodegradable, non-animal stabilized HA.
However, no biphasic fillers having suitable viscoelasticity
and particle texturing feel (PTF) were made in Korea to
replace the Restylane fillers. Therefore, the development
of the domestic biphasic fillers is necessary.
Restylane® products (biphasic gel) are the most widely
used fillers in the market. The ratio of CHA to NHA is
75:25, which is attributed to the restoration of facial
volume [7]. Crosslinked gel nanoparticles are previously
studied to feel the particle texture. Nanoparticles are
synthesized after the consumption of carboxyl groups by
crosslinker of adipic acid dihydrazide [7–11]. The nano-
particle size decreases from 140 nm to 95 nm with in-
creasing the HA molecular weight (MW) from 697 kDa
to 1368 kDa [12]. The decrease in nanoparticle size with
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increasing the MW may be due to intramolecular cross-
linking rather than intermolecular crosslinking [9]. How-
ever, the flowability of nanoparticles rises dramatically
due to the loss of viscous modulus, which is detrimental
to dermal fillers. The elastic modulus (G’) is determined
to be 178 Pa for the fillers composed of 15 % crosslinked
nanoparticles suspended in 85 % of NHA [12]. Although
the elastic modulus is similar to that of Restylane®
(175 Pa), the amount of the CHA decreases dramatically
from 85 to 15 %, which is detrimental to facial volume
and fullness to the skin as dermal fillers. The 15 % portion
is also very low as compared to those (60 ~ 70 %) of mono-
phasic fillers [12, 13]. In addition, PTF is not achieved
probably due to poor elasticity of nanoparticles [13].
HA dermal fillers having different ratios (65/35 to 95/5)
of CHA microspheres (CHMs, 1058 kDa) to NHAs are
synthesized to investigate the effect of CHMs on the vari-
ation of viscoelasticity and PTF [13]. The diameters of
CHMs are in the range of 60 to 100 ± 4 μm with a 3-D
porous structure channeled with 2 to 4 ± 0.5 μm. The
fillers consist of gel particles with 300 ± 30 μm in size. G’
increased from 211 Pa to 700 Pa with raising the volume
fraction of CHM from 65 to 95. The fillers having the
CHM ratios of 65 to 85 exhibit the G’ values in the range
of 175 Pa to 430 Pa, which can be extruded through the
29 ~ 30-gage needle. Experimental results revealed that
PTF rose with increasing the volume fraction of CHM
due to high density of gel particles. Excellent gel inject-
ability and PTF were successfully achieved. In the
present study, HA dermal fillers were prepared by using
CHMs made from different MWs (697 kDa and 1058 kDa)




HA with different MWs (697, 1058 and 1368 kDa) was
purchased from Shiseido Company (Tokyo, Japan). Divinyl
sulfone (DVS, 97 %) was purchased from Sigma-Aldrich
(Germany). 2-methyl-1-propanol (99 %), ethanol (99.5 %),
and sodium hydroxide (bead, 98 %) were obtained from
Samchun Pure Chemical Company (Korea).
Microsphere preparation
HA solutions of 0.5 wt.% concentration were prepared by
dissolving sodium hyaluronates (Streptococcus, Mw =697
and 1058 kDa, Shiseido Co., Japan) in 0.05 mol/L NaOH
for 24 h at room temperature. A pH in the range of 11 to
12 was adjusted by adding 10 mol/L NaOH to the HA
solution. Then, the HA solution was placed in a solu-
tion hopper attached to the Masterflex L/S tubing pump
(Cole Parmer, USA) and fed into a syringe equipped with
a 22-gage metal needle with a flat outlet at a flow rate of
0.005 mL/min [13–16]. The distance between the nozzle
and the solution was 4 cm. Microspheres (MSs) were fab-
ricated by supplying compressed air (0.034 MPa) along
the HA solution nozzle. The nozzle was enclosed by a de-
livery tube with a diameter of 6 mm. MSs were collected
in a solution mixture of 0.2 vol.% of DVS in 2-methyl-1-
propanol, followed by a stirring process (MST Digital,
IKA, Germany) for 24 h at RT. Then, the crosslinked MSs
were screened through a 325 mesh sieve. The MSs were
immersed in distilled water for 0.5 h and ethanol for 0.5 h
to remove the residual crosslinker. After removal of an
unreacted residual crosslinker, the MSs were then dried
for 2 h at 60 °C in a vacuum of 20 Torr. The as-dried MSs
were examined by using SEM (S-3000H, Hitachi, Japan)
and optical microscopy (SV-55, Sometech, Korea) to in-
vestigate the morphology and the size of the MSs. Prior to
the SEM measurements, all specimens were coated with
Au/Pd to ensure higher conductivity.
Hydrogels
The HA hydrogels (HAHs) are biphasic products con-
sisting of CHMs (697 and 1058 kDa) suspended in NHA
(1368 kDa) used as a carrier. For gel preparation, NHAs
(20 mg/mL) dissolved in a phosphate buffered saline
solution (PBS, NaH2PO4) and swollen CHMs were ho-
mogenized for 1 ~ 4 min and then incubated for 24 h
[12, 13]. The ratio of CHA to NHA is varied from 65:35
to 95:5. The elastic and viscous response of hydrogel
depend on the concentration and MW of the HA and on
the frequency used during the measurements. Rheological
behavior of HAHs were analyzed with a Thermo Haake
RS1 Rheometer (Newington, USA), using a plate and
plate geometry with a 1.2 mm gap [12, 13]. All mea-
surements were performed using a 20 mm titanium
sensor at 25 °C. Oscillation measurements were taken
at 5 Pa tau over a frequency range of 0.01 to 100 Hz
[13]. The measured properties of hydrogels was evalu-
ated by measuring the elastic modulus (G’) and viscous
modulus (G”). The measured modulus at frequency of
5 Hz for HAHs was compared [12]. In addition, PTF is
evaluated by observing or touching the gels using an
optical microscope (Pro Camscope, Sometech, Korea)
or fingers, respectively.
Swelling property
The swelling characteristics were measured by immersing
weighed samples of dry MSs for 24 h in PBS. The excess
surface water in the swollen gel was removed by blotting
and then the swollen gel was weighed. After measuring
the weight of the gels, the swelling ratio was determined
[12, 13].
Cytotoxicity
The extract test method was conducted on the HAHs
to evaluate the potential of cytotoxicity on the base of
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the International Organization for Standardization
(ISO 10993–5). The HAHs were extracted aseptically in
single strength Minimum Essential Medium (1X MEM)
with serum. The ratio of HAH to extraction vehicle was
4 g/20 mL. The test sample was used within 24 h after
completion of the preparation. The test extract was
placed onto three separate confluent monolayers of L-
929 (NCTC Clone 929, ATCC, USA) mouse fibroblast
cells propagated in 5 % CO2. For this test, confluent
monolayer cells were trypsinized and seeded in 10 cm2
wells (35 mm dishes). Simultaneously, triplicates of reagent
control, negative control (high density polyethylene film,
RM-C), and positive control (polyurethane film, RM-A)
were placed onto the confluent L-929 monolayers. All
monolayers were incubated for 48 h at 37 °C in the
presence of 5 % CO2. After incubation, the morpho-
logical change of the cell was examined to assess the
biological reaction by using the inverted microscope
(TS100-F, Nikon, Japan) and the iMark microplate ab-
sorbance spectrophotometer (Bio-Rad, USA). Water-
soluble tetrazolium salts (WSTs) are a series of other
water-soluble dyes for MTT assays, which can provide
different absorption spectra of the formed formazans.
EZ-cytox yields a water-soluble formazan, which can be
read directly. The absorbance of the colored solution is
quantified by measuring at a wavelength of 415 nm with
the iMark microplate absorbance spectrophotometer. The
value of untreated cell (control sample, only cultured with
culture medium) was set as 100 % and those of the
treated cells were expressed as the percentage of the
control sample.
Particle texturing feel (PTF)
It is hard to quantify the PTF using an optical microscope
or fingers. Although touching gels with hands is very sub-
jective, PTF is scaled qualitatively from 0 (lowest) to 10
(highest) to provide more understanding. When MSs were
easily broken like gels and disappeared, PTF may be 0 ~ 2.
PTF is determined to be 7 ~ 9 when MSs were remained
as particles on fingers after rubbing repeatedly.
Statistical analysis
All experiments were performed in triplicate. Values in
the text are expressed as the means ± standard deviation
(SD), and p < 0.05 was considered statistically significant.
Results and discussion
Morphology of crosslinked microspheres
Two types of CHMs having different MWs (697 and
1058 kDa) were fabricated [13–19]. The average diame-
ter of CHMs (HA = 697 and 1058 kDa) was in the range
of 158 ± 16 μm and 100 ± 4 μm and the swelling rate of
1270 and 1000 %, respectively. The MW of HA used for
MS fabrication influenced the size of the MS. The MSs
made from 697 kDa HA were larger than the MSs pre-
pared from 1058 kDa probably due to the intramolecular
crosslinking rather than the intermolecular crosslinking
caused by the short length of 697 kDa HA [9].
Morphologically the MSs were white colored spheres
having a smooth surface, as shown in Figs. 1 and 2. Hollow
structure of the MSs made from 697 kDa HA was ob-
served. The hollow MSs were an outerlayer of 10 ± 0.5 μm
in thickness channeled with 1.7 ± 0.3 μm pores, which was
Fig. 1 SEM images of (a–d) CHMs (HA = 697 kDa). Note that b ~ d images exhibit hollow structure inside the MS
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indicative of poor particle compressibility (Fig. 1). In con-
trast, no pores on the surface of MSs made from 1058 kDa
HA were visible. However, pores inside the MSs were easily
seen (Fig. 2). The MSs were a 3-dimensional porous net-
work structure channeled with 2 ~ 4 ± 0.5 μm pores, which
represented higher particle compressibility [9].
Biocompatibility
The HAHs were prepared by immersing the MSs in PBS
solution by varying the ratio of CHA to NHA from
65:35 to 95:5. They can be used as the tissue membrane
to release of entrapped drug under a certain condition in
a controlled manner. It could be used to encapsulate
and cultivate cells inside the gel, where the network will
act as a semipermeable membrane allowing only growth
factors to enter to aid the growth of cells [13]. MSs were
crosslinked with DVS, followed by cleaning in ethanol
and distilled water. Covalent linkages between polymer
chains can be obtained by the reaction of functional
groups of a DVS crosslinking agent (vinyl group) and HA
(hydroxyl group) [11–24]. The presence of crosslinker’s
residue in the HA hydrogels after cleaning was not de-
tected after cleaning, suggesting that the unreacted re-
sidual crosslinker was successfully removed [12, 13].
A cytotoxicity test of the HAHs determines whether a
product or compound will have a toxic effect on living
cells. The test extract with the 75/25 ratio of CHA
(1058 kDa) to NHA (1368 kDa) showed no evidence of
causing cell lysis or toxicity, as depicted in Fig. 3. The
HAHs exhibited equal or higher average cell amount
(100.6 %) compared to the negative control, as verified by
the microscope and the absorbance spectrophotometer.
The qualitative morphological grading of cytotoxicity of
extracts was determined to be scale 0.
The biocompatibilities of HA hydrogels, such as geno-
toxicity (in vitro chromosome aberration test, reverse mu-
tation assay, in vivo micronucleus test), skin sensitization,
intradermal reactivity, and pyrogenicity, were previously
evaluated and determined to be suitable for soft tissue
augmentation due to the absence of abnormal clinical
signs [14, 15]. There was no difference between the HAHs
and negative control mean scores because skin reaction
such as erythema or oedema was not observed after injec-
tion. In addition, the HAHs had no subchronic systemic
toxicity, indicating that the implants were excellent in bio-
logical synthesis and transplantation as evidenced by non-
capsule reaction and disappearance of inflammatory cells
[16]. It was reported that the implants of HAHs are
clinically safe and effective.
Viscoelastic property
Since the filling capacity of a dermal filler is known to
be dependent on its water uptake capacity, the swelling
ratio was examined. It is suggested that the highest
water uptake indicates a lower crosslinking extent with
respect to the other gels. On the contrary, the lowest
swelling capacity may be due to a higher crosslinking
density [12, 13]. It was evident that the expansion cap-
acity of HA hydrogels rose with increasing the amount
of NHA and was inversely proportional to the crosslink-
ing degree [12, 13, 18]. The swelling ratios of NHA hav-
ing the MW of 1368 kDa and the CHMs made from
MW of 697 and 1058 kDa were 4000, 1260, and 1000 %,
Fig. 2 SEM images of (a–d) CHMs for 24 h. Note that b ~ d images exhibit porous network inside the MSs
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respectively [12, 13]. The swelling ratio of NHA in-
creases with increasing MW. However, the swelling ratio
of CHMs decreases with increasing MW probably due
to an increased number of coiled HA chain interactions
[12–17]. Because of short length of 697 kDa HA, the
chances of intramolecular crosslinking occurring during
the fabrication of MSs was expected to be higher than
those of intermolecular crosslinking [9].
The ratios of CHA to NHA for commercially avail-
able dermal fillers are 98:2 for Hylaform/Prevelle, 75:25
for Restylane/Perlane, 60:40 for Juvederm (30 HV), res-
pectively. In the present study, MSs made from 697 kDa
and 1058 kDa HA were blended with 1368 kDa NHA. G’
of HA hydrogels was evaluated as a function of the
volume fraction of CHA to NHA in the range of 65:35 to
95:5. Among the commercial fillers, Restylane is biphasic
products consisting of CHM (75 %) suspended in NHA
(25 %) used as a carrier.
The filling capacity is also affected by the surrounding
tissue resistance to gel enlargement and by the rheo-
logical behavior of the filler itself during in situ implant-
ation. To achieve correction of lines and wrinkles and
restore volume, the gel implant should lift the tissue.
The strong gel can provide the force required to lift the
tissue and resist subsequent deformation, resulting in the
desired correction. A high lifting capacity therefore re-
quires high gel strength. The elastic modulus represents
the stiffness of the gels and the ease of extrusion of the
product. A 3-dimensional network of HAHs is easily
formed when crosslinks between the HA chains are intro-
duced. A strong gel has a high elasticity, meaning that the
response to deformation is mainly elastic [2–4].
It is known that more deformable gels, having lower
G’ values ranging from 120 Pa to 430 Pa, can be injected
through the finer needles between 29 and 30 gage [6]. In
contrast, larger needles (26 ~ 27 gage) are required for
the extrusion of firmer gels (1400 ~ 1800 Pa). The G’
value of commercial soft skin filler, Restylane Skinbooster,
is determined to be 175 Pa [12]. The G’ values of HA
fillers having different ratios of DVS CHA to NHA are
shown in Fig. 4. The G’ values increased from 71 ~ 177 Pa
to 211 ~ 702 Pa with increasing the HA MW from
697 kDa to 1058 kDa. The fillers having the ratio of the
CHA (697 kDa) to the NHA between 85:25 and 95:5
showed the G’ values in the range of 137 Pa to 177 Pa.
The low G’ values of the fillers made from 697 kDa may
Fig. 3 Photographs of cell morphology: a positive control, b negative control, and c the extract of HAHs from WST assay (EZ-cytox) after
exposing with HAH suspensions for 48 h
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Fig. 4 Elastic modulus as a function of concentration of CHA. Note
that the region of the dotted lines represents the easy delivery of
the fillers through a 29 ~ 30 gage needle
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be due to hollow structure of MS as a result of intramo-
lecular crosslinking [19]. The G’ value of 177 Pa is ob-
served only for the fillers containing 95 % of CHA MS,
which is similar to that of Restylane products (175 Pa).
Rest of the fillers made from 697 kDa HA do not meet G’
values of the commercial fillers, as displayed in Fig. 4. On
the other hand, the fillers having the ratio of the CHA
(1058 kDa) to the NHA between 65:35 and 85:25 showed
the G’ values in the range of 175 Pa to 430 Pa [13]. They
can be extruded through the 29 ~ 30-gage needle allowing
for ease of injection, which can be applicable to the treat-
ment of non-severe defects and generally for thinner and
softer skin rather than the correction of deep folds and
skin deformation [4]. The content of CHM is in the range
of 65 to 85, which is similar to Restylane products widely
used in the market [7, 13, 24]. The elastic moduli of the
as-prepared fillers (211 ~ 420 Pa) are even stiffer than that
of Restylane products (175 Pa) [13].
PTF
Unlike the monophasic fillers, the commercial Restylane
fillers show PTF when touching gels with hands. The
biphasic fillers prepared in the present study consist of
crosslinked micro-sized gel particles suspended in NHA.
Our previous studies revealed that the crosslinked nano-
particles of the dermal fillers increased the flowability
dramatically, which was detrimental to PTF (scale 0)
[12]. The nanoparticles contain a less-accessible cross-
linked polymer structure, thus reducing polymer chain
interactions and thereby lowering the viscosity. Viscous
modulus (G”) is also called loss modulus because it de-
scribes the energy that is lost as viscous dissipation. The
G” value is a measure of the flow (rheological) properties
for the fillers. The G” values as a function of concentra-
tion of crosslinked HA are shown in Fig. 5. Appreciable
difference in G” is found. The G” values of the fillers
made from 697 kDa are in the range of 25 to 108 Pa,
which is lower than those of commercial products. The
PTF scale is likely to be in the range of 1 to 2. However,
the fillers made from 1058 kDa show higher values than
128 Pa, which correspond to the PTF scale in the range
of 7 to 9. The G” values of the as-prepared fillers (129 to
214 Pa) are better than those of Restylane (119 Pa) and
Perlane (125 Pa), which are categorized in the medium-
viscosity and –elasticity group [25, 26].
PTF is evaluated qualitatively by observing or touching
the gels using an optical microscope or fingers due to
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Fig. 5 Viscous modulus as a function of concentration of CHAs made
from 697 kDa and 1058 kDa HA
Fig. 6 Optical photographs of the fillers having the volume fraction of CHMs (Mw = 697 kDa): a 65 %, b 75 %, c 85 %, and d 95 %, respectively
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the presence of crosslinked gel particles, respectively. No
appreciable difference of CHM images can be found
(Fig. 6 and reference 13). The swollen particle size made
from 697 kDa and 1058 kDa HA is 260 ± 48 μm and
300 ± 30 μm, respectively. Although no flowability is de-
tected for both fillers, PTF of fillers made from 697 kDa
HA is not tangible due to poor compressibility of MSs,
as verified by SEM observation and viscoelastic proper-
ties. However, excellent PTF is observed for the fillers
made from 1058 kDa. As the volume fraction of CMSs
increased, the particle density rose as expected. It can be
concluded that the dermal biphasic fillers possessing the
tailored elasticity and PTF are successfully achieved for
the fillers made from 1058 kDa HA.
Conclusions
Viscoelasticity of HA dermal fillers, made from 697 kDa
and 1058 kDa HA suspended in NHA (1368 kDa), is ex-
amined by using the SEM, the optical microscope, and
the rheometer. The average diameter of CHMs made
from 697 kDa and 1058 kDa HA is 158 ± 16 μm and
100 ± 4 μm and the swelling ratio of 1270, 1000 %, respect-
ively. Unlike the fillers made from 697 kDa HA, the fillers
(1058 kDa) exhibit tailored elastic moduli (211 ~ 420 Pa)
and viscous moduli (129 ~ 214 Pa), which are adequate for
dermal biphasic fillers. PTF (scale 7 ~ 9) is also successfully
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